Drug Shortage Report for VALSARTAN-HCTZ
| Report ID | 104493 |
| Drug Identification Number | 02367785 |
| Brand name | VALSARTAN-HCTZ |
| Common or Proper name | VALSARTAN HCTZ |
| Company Name | PRO DOC LIMITEE |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE VALSARTAN |
| Strength(s) | 25MG 160MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30,100 |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2020-01-27 |
| Estimated end date | Unknown |
| Actual end date | 2020-02-06 |
| Shortage status | Resolved |
| Updated date | 2020-02-07 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
| Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2020-02-07 | English | Compare |
| v4 | 2020-02-06 | French | Compare |
| v3 | 2020-02-06 | English | Compare |
| v2 | 2020-01-28 | French | Compare |
| v1 | 2020-01-28 | English | Compare |
Showing 1 to 5 of 5